Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Mining
- Aerospace & Air Transport
- Oil, Gas & Refineries
- Water and Wastewater
- Environmental
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
- Energy
- Construction & Construction Materials
Acute Leukemia Suppliers Serving Namibia
13 companies found
based inLund, SWEDEN
Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...
Ongoing work to comply with the CE-IVDR (clinical use). The program includes classifier models and supportive gene fusion analysis. Qlucore Diagnostics is a scalable diagnostic solution from data to report, improving clinical? workflow? with ...
based inSeocho-gu, SOUTH KOREA
Taking the first step in 1945, JW Group has found the market for domestic therapeutic drug based on its philosophy of respecting life and pioneering spirit. We are strengthening our global market competitiveness by developing leading health care ...
based inRoyston, UNITED KINGDOM
Over 30 years experience manufacturing gas detection instruments and sensors. ION Science has over 30 years of industry experience designing, manufacturing, and supplying PID gas sensors, gas detection instruments, and leak detectors for a wide ...
based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
based inDaxing District, CHINA
Beijing Challen Biotechnology Co., Ltd. (Challenbio) is a leading Chinese flow cytometer manufacturer, located in Biomedical Base of Daxing District, Beijing. It is a high- technology company specializing in R&D, production and sales of biomedical ...
Our product production process strictly follows relevant standards and undergoes multiple rigorous tests to ensure product quality. We pay great attention to details and use a rigorous attitude to ensure the smooth progress of your experiment or ...
based inHayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
CD45 is a Type I trans-membrane protein which is in various forms present on all differentiated hematopoietic cells except erythrocytes and assists in the activation of those cells (a form of co-stimulation). It is expressed in Lymphomas, B-cell ...
based inPleasanton, CALIFORNIA (USA)
Since 1994, Diagnostic BioSystems Inc. is committed to enhancing immunohistochemistry results by providing innovative anatomic pathology reagents and systems to improve the practice of pathology. Since the inception, our prime focus has been to ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
based inWoodland Hills, CALIFORNIA (USA)
EntroGen offers end-to-end molecular diagnostic solutions by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with proprietary software embedded for key decision ...
Mutations in IDH1/2 can lead to the development and/or progression of various types of cancer including secondary glioblastomas and acute myeloid leukemias (AML). IDH1/2 mutations are linked to abnormal histone and ...
based inAbbiategrasso, ITALY
Since 1987, Clonit has been focused in developing, manufacturing and distributing of innovative and reliable in Vitro Diagnostic Equipment and Reagents for Molecular Diagnostics. A deep expertise in Molecular Biology mixed to our strong culture of ...
The device is intended for detecting the presence of gene fusion resulting from the t(8;21)(q22;q22), the most frequently observed chromosomal aberration associated with Acute Myeloid Leukemia (AML), and for ...
based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Pursuing an Unmet Need in the Treatment of AML - SENTI-202 is designed to target and eliminate acute myeloid leukemia cells while sparing healthy bone marrow. Our vision is a potential medicine that does not rely on ...
based inNewark, DELAWARE (USA)
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in ...